Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
27.6M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
6.95M
-
Shares change
-
+859K
-
Total reported value, excl. options
-
$21.3M
-
Value change
-
+$2.59M
-
Number of buys
-
8
-
Number of sells
-
-5
-
Price
-
$3.06
Significant Holders of BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) as of Q3 2021
19 filings reported holding PHGE - BiomX Inc. - Common stock, par value $0.0001 per share as of Q3 2021.
BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.95M shares
of 27.6M outstanding shares and own 25.17% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2.81M shares), JOHNSON & JOHNSON (2.13M shares), MMCAP International Inc. SPC (684K shares), Kepos Capital LP (451K shares), MILLENNIUM MANAGEMENT LLC (295K shares), ROYCE & ASSOCIATES LP (226K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (201K shares), JANE STREET GROUP, LLC (43.9K shares), RENAISSANCE TECHNOLOGIES LLC (41.8K shares), and Taylor Wealth Management Partners (25.5K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.